Back
Zomedica Vs. LENSAR Industry Stock Comparison
Buy
64
ZOM
Zomedica
Last Price:
0.13
Seasonality Move:
422.85%
Buy
71
LNSR
LENSAR
Last Price:
7.56
Seasonality Move:
13.42%
Buy
64
Zomedica (ZOM)
is a Buy
Is Zomedica a Buy, Sell or Hold?
- The current Zomedica [ZOM] share price is $0.13. The Score for ZOM is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- ZOM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
71
LENSAR (LNSR)
is a Buy
Is LENSAR a Buy, Sell or Hold?
- The current LENSAR [LNSR] share price is $7.45. The Score for LNSR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- LNSR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ZOM Stock Price Chart
LNSR Stock Price Chart
ZOM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0 | Buy |
Relative Strength Index (14 RSI): | 53.2 | Buy |
Chaikin Money Flow: | -2202196 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.12 - 0.14) | Buy |
Bollinger Bands (100): | (0.13 - 0.15) | Sell |
LNSR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.59 | Buy |
Relative Strength Index (14 RSI): | 66.96 | Buy |
Chaikin Money Flow: | -69928 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.44 - 7.16) | Buy |
Bollinger Bands (100): | (4.19 - 5.97) | Buy |
ZOM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.13 | Sell |
20-day SMA: | 0.13 | Buy |
50-day SMA: | 0.13 | Buy |
200-day SMA: | 0.14 | Sell |
8-day EMA: | 0.13 | Buy |
20-day EMA: | 0.13 | Buy |
50-day EMA: | 0.13 | Buy |
200-day EMA: | 0.14 | Sell |
LNSR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.27 | Buy |
20-day SMA: | 6.52 | Buy |
50-day SMA: | 5.48 | Buy |
200-day SMA: | 4.56 | Buy |
8-day EMA: | 7.21 | Buy |
20-day EMA: | 6.66 | Buy |
50-day EMA: | 5.84 | Buy |
200-day EMA: | 4.7 | Buy |
Zomedica Earnings Growth & ZOM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
LENSAR Earnings Growth & LNSR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.34 per share, and an increase next year of $0.72 per share.
Zomedica Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
LENSAR Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |